EE13 Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Portugal
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.267
https://www.valueinhealthjournal.com/article/S1098-3015(22)02471-8/fulltext
Section Title :
Section Order :
12069
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02471-8&doi=10.1016/j.jval.2022.09.267